tolvaptan has been researched along with Dyspnea in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Kim, S; Kinugawa, K; Nakata, E | 1 |
| Han, D; Shang, W; Zhang, Y | 1 |
| Li, J; Yin, C; Yuan, L | 1 |
| Chen, S; Du, R; Han, S; Li, J; Liu, M; Wang, L; Zhang, Q | 1 |
| Cai, L; Wang, C; Xiong, B | 1 |
| Abdulhadi, B; Mezue, K; Rangaswami, J | 1 |
| Kajimoto, K; Otsubo, S | 1 |
| Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Ambrosy, AP; Butler, J; Chioncel, O; Gheorghiade, M; Greene, SJ; Khan, H; Konstam, MA; Maggioni, AP; Mentz, RJ; Subacuis, HP; Swedberg, K; Udelson, JE; Vaduganathan, M; Zannad, F | 1 |
| Adams, KF; Cole, RT; Echols, M; Egnaczyk, GF; Felker, GM; Fiuzat, M; Gupta, D; Khouri, MG; Mentz, RJ; Monds, P; O'Connor, CM; Patel, CB; Roberts, R; Tauras, JM | 1 |
| Chandler, A; Dhingra, R; Dowling, D; Eisen, H; Fileccia, R; Gordon, P; Gregory, D; Gupta, D; Haught, WH; Kiernan, M; Konstam, JM; Konstam, MA; Korr, K; Massaro, JM; Mody, FV; Patten, R; Pressler, SJ; Romeling, M; Udelson, JE; Wagoner, L; Wedge, P | 1 |
| Blair, JE; Burnett, JC; Gheorghiade, M; Grinfeld, L; Konstam, MA; Krasa, HB; Maggioni, AP; Ouyang, J; Pang, PS; Swedberg, K; Teerlink, JR; Udelson, JE; Zannad, F; Zimmer, C | 1 |
4 review(s) available for tolvaptan and Dyspnea
| Article | Year |
|---|---|
Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
Topics: Antidiuretic Hormone Receptor Antagonists; Dyspnea; Heart Failure; Humans; Tolvaptan | 2022 |
Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dyspnea; Heart Failure; Humans; Tolvaptan | 2023 |
Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Dyspnea; Heart Failure; Humans; Prognosis; Tolvaptan | 2019 |
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Recovery of Function; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
5 trial(s) available for tolvaptan and Dyspnea
| Article | Year |
|---|---|
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss | 2013 |
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Double-Blind Method; Dyspnea; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Predictive Value of Tests; Prospective Studies; Quality of Life; Recovery of Function; Risk Factors; Stroke Volume; Surveys and Questionnaires; Time Factors; Tolvaptan; Treatment Outcome; Ventricular Function, Left | 2016 |
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Tolvaptan | 2017 |
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Tolvaptan; Water-Electrolyte Imbalance | 2017 |
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
Topics: Aged; Benzazepines; Double-Blind Method; Dyspnea; Female; Humans; Male; Pulmonary Atelectasis; Respiratory System Agents; Tolvaptan; Treatment Outcome | 2009 |
3 other study(ies) available for tolvaptan and Dyspnea
| Article | Year |
|---|---|
Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Dyspnea; Edema; Heart Failure; Humans; Prodrugs; Tolvaptan | 2022 |
Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
Topics: Dyspnea; Heart Failure; Humans; Renal Insufficiency, Chronic; Tolvaptan | 2017 |
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Tolvaptan | 2019 |